NewAmsterdam Pharma Co N.V. SEC filings NAMS
NewAmsterdam Pharma Co N.V. has 415 filings in SEC EDGAR's recent list, going back to Aug 4, 2022. Its latest annual report, Form ARS, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K | Current report | Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 22, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 21, 2026 | Sep 21, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 144/A | Filing | Aug 25, 2026 | — |
| 4 | Insider transaction | Aug 25, 2026 | Aug 24, 2026 |
| 144 | Notice of proposed sale | Aug 24, 2026 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 14, 2026 | Jul 16, 2026 |
| 3 | Initial insider ownership | Aug 14, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 4, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 26, 2026 |
| 144 | Notice of proposed sale | May 26, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| ARS | Annual report to shareholders | May 6, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 11, 2026 | — |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 144 | Notice of proposed sale | Feb 20, 2026 | — |
| S-8 | Employee stock plan registration | Feb 18, 2026 | — |
| 10-K | Annual report | Feb 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Jan 29, 2026 | Jan 27, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 4 | Insider transaction | Dec 29, 2025 | Dec 23, 2025 |
| 144 | Notice of proposed sale | Dec 23, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 4, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 4, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| 4 | Insider transaction | Sep 17, 2025 | Sep 15, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 144 | Notice of proposed sale | Sep 9, 2025 | — |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 144 | Notice of proposed sale | Sep 3, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 144 | Notice of proposed sale | Aug 25, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 20, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 15, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 17, 2025 | Jul 15, 2025 |
| 144 | Notice of proposed sale | Jul 14, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 144 | Notice of proposed sale | Jun 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 3 | Initial insider ownership | Jun 3, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 144 | Notice of proposed sale | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2025 | — |
| ARS | Annual report to shareholders | May 8, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | May 8, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 7, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 2, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 2, 2025 | May 1, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 28, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 14, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2025 | Apr 15, 2025 |
| 144 | Notice of proposed sale | Apr 11, 2025 | — |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 144 | Notice of proposed sale | Mar 26, 2025 | — |
| 144 | Notice of proposed sale | Mar 26, 2025 | — |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| EFFECT | Filing | Mar 10, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| 4 | Insider transaction | Mar 5, 2025 | Mar 4, 2025 |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2025 | — |
| S-3 | Shelf registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 7, 2025 |
| S-8 | Employee stock plan registration | Jan 7, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 30, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 26, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 20, 2024 | Dec 18, 2024 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 17, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 13, 2024 | Dec 11, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NAMS (Nasdaq), NAMSW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Narrden, Netherlands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1936258
- Former names
- NewAmsterdam Pharma Co B.V. (until Nov 22, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.